When adult-use eclipses medical: How recreational cannabis legalization has undermined patient care
The Cannigma
JULY 18, 2025
First reported in Europe in 2004 and widely identified in 2008, substances such as JWH-018 (a potent full agonist of CB1/CB2 receptors) and others have since proliferated globally (Darke et al., This includes overseeing continued access to hemp-derived, full-spectrum CBD products containing 0.3% ScienceDirect, 2021).
Let's personalize your content